Keros Therapeutics Inc. (KROS)

AI Score

Unlock

14.07

0.54 (3.99%)

At close: Apr 17, 2025, 3:59 PM

14.07

0.00%

After-hours: Apr 17, 2025, 07:47 PM EDT

Keros Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	559.93M	530.68M	405.86M	442.44M	331.15M	287.89M	322.03M	351.43M	279.05M	239.43M	215.62M	228.59M	230.04M	221.35M	237.11M	255.2M	265.88M	133.81M	144.69M	54.52M	7.02M	-23.26M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46.52M
Long-Term Investments	n/a	n/a	1.21M	1.21M	1.21M	1.21M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	115K	115K	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	3.5M	3.04M	2.15M	2.05M	2.05M	1.57M	1.57M	1.59M	2.12M	3.22M	667K	275K	82K	n/a	n/a	n/a	115K	115K	115K	115K	115K	-23.26M
Receivables	4.46M	1.92M	1.34M	1.78M	1.09M	898K	964K	1.15M	841K	146K	146K	167K	18M	169K	245K	n/a	216K	172K	238K	977K	922K	n/a
Inventory	n/a	n/a	1.00	1.00	14.05M	15.32M	10.94M	9.13M	-841K	5.56M	6.12M	2.22M	3.06M	4.24M	3.77M	n/a	1.47M	2.3M	3.31M	2.61M	759K	n/a
Other Current Assets	1.48M	1.39M	582K	616K	1M	319K	376K	515K	180K	745K	466K	251K	340K	313K	290K	265K	160K	130K	279K	2.35M	819K	n/a
Total Current Assets	588.89M	552.05M	432.71M	463.13M	347.29M	304.44M	334.31M	362.22M	285.77M	245.88M	222.36M	231.22M	251.44M	226.07M	241.42M	255.98M	267.73M	136.42M	148.52M	58.54M	8.93M	23.26M
Property-Plant & Equipment	23.49M	24.19M	18.94M	19.43M	19.47M	19.03M	19.1M	19.3M	17.57M	2.13M	2.31M	2.32M	2.4M	2.56M	1.93M	1.63M	1.6M	1.72M	1.81M	1.94M	1.91M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	26.99M	27.23M	22.31M	22.69M	22.73M	21.81M	22M	22.21M	21.01M	6.67M	4.3M	3.92M	3.81M	3.89M	2.04M	1.75M	1.72M	1.83M	1.92M	2.05M	2.03M	-23.26M
Total Assets	615.89M	579.27M	455.02M	485.82M	370.02M	326.25M	356.31M	384.44M	306.78M	252.55M	226.66M	235.14M	255.25M	229.96M	243.46M	257.73M	269.44M	138.25M	150.44M	60.59M	10.96M	n/a
Account Payables	4.6M	4.98M	6.54M	4.99M	5.45M	3.87M	4.15M	4.68M	3.34M	2.65M	7.66M	3.06M	3.65M	2.81M	1.37M	3.01M	2.15M	1.72M	4.85M	2.43M	2.09M	n/a
Deferred Revenue	n/a	n/a	n/a	-1.05M	17.25M	11.82M	n/a	n/a	n/a	n/a	n/a	n/a	7.13M	7.16M	5.04M	5.3M	4.39M	4.26M	2.62M	5.8M	1.92M	n/a
Short-Term Debt	n/a	n/a	1.1M	1.05M	n/a	611K	n/a	n/a	n/a	455K	670K	884K	n/a	843K	449K	436K	n/a	412K	400K	388K	n/a	n/a
Other Current Liabilities	10.55M	8.38M	7.21M	7.7M	10.38M	5.9M	4.49M	7.96M	7.89M	4.05M	3.63M	5.5M	4.86M	4.67M	3.99M	4.29M	2.92M	3.08M	1.79M	5.2M	1.02M	n/a
Total Current Liabilities	27.45M	29.01M	21.25M	18.72M	24.37M	16.7M	16.09M	15.46M	16.55M	11.53M	15.45M	11.65M	11.85M	11.02M	7.53M	8.95M	7.18M	6.83M	8.29M	8.84M	4.49M	n/a
Long-Term Debt	n/a	n/a	12.86M	13.15M	n/a	13.7M	13.95M	13.99M	n/a	n/a	n/a	n/a	n/a	453K	242K	361K	n/a	586K	692K	797K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-12.86M	-13.15M	n/a	-13.7M	-13.95M	-13.99M	n/a	n/a	n/a	n/a	n/a	-437K	-210K	-314K	62K	-509K	-601K	-693K	119K	n/a
Total Long-Term Liabilities	16.88M	17.43M	12.86M	13.15M	13.44M	13.7M	13.95M	13.99M	12.81M	455K	670K	3.95M	231K	469K	274K	408K	538K	663K	783K	901K	1.02M	n/a
Total Liabilities	44.33M	46.44M	34.11M	31.87M	37.81M	30.41M	30.05M	29.45M	29.36M	11.53M	15.45M	11.65M	12.08M	11.48M	7.8M	9.36M	7.72M	7.49M	9.08M	9.74M	5.5M	n/a
Total Debt	18.86M	19.29M	13.96M	14.2M	14.44M	14.31M	13.95M	13.99M	13.27M	455K	670K	884K	1.09M	1.3M	691K	797K	899K	998K	1.09M	1.19M	1.27M	n/a
Common Stock	4K	4K	3K	3K	3K	3K	3K	3K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	1K	2K	n/a
Retained Earnings	-568.78M	-522.75M	-469.8M	-424.54M	-381.43M	-341.18M	-301.74M	-264.24M	-228.43M	-198.72M	-175.21M	-147.94M	-123.75M	-116.81M	-96.52M	-80.9M	-65.01M	-54.34M	-42.3M	-31.54M	-19.65M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	0.00	-0.00	n/a	-0.00	-0.00	0.00	-0.00	n/a	-0.00	n/a	-0.00	-0.00	-0.00	-138.25M	-150.44M	n/a	-453K	-7.18M
Shareholders Equity	571.55M	532.84M	420.92M	453.95M	332.21M	295.84M	326.26M	354.98M	277.42M	241.03M	211.21M	223.49M	243.17M	218.48M	235.66M	248.37M	261.72M	130.76M	141.36M	50.85M	5.45M	12.76M
Total Investments	n/a	n/a	1.21M	1.21M	1.21M	1.21M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	1.33M	115K	115K	n/a	n/a	n/a	n/a	n/a	46.52M